Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lapaquistat Acetate in Primary Dyslipidemia
NCT00487994Phase 3Completed
- Sponsor
- Takeda
- Start
- Nov 2004
- Primary completion
- May 2007
- Modality
- Small Molecules
- Countries
- 17
01
Overview
A Phase 3 trial of lapaquistat in primary dyslipidemia, sponsored by Takeda. Started Nov 2004; status: completed.
02
Drugs
lapaquistat
03
Conditions
primary dyslipidemia
Beyond the preview
Go deeper on NCT00487994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00487994.